Goldman Sachs’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $965K | Buy |
|
|||||
|
2025
Q1 | $783K | Sell |
|
|||||
|
2024
Q4 | $2.16M | Buy |
|
|||||
|
2024
Q3 | $1.97M | Buy |
|
|||||
|
2024
Q2 | $1.36M | Buy |
|
|||||
|
2024
Q1 | $775K | Sell |
|
|||||
|
2023
Q4 | $928K | Buy |
|
|||||
|
2023
Q3 | $571K | Buy |
|
|||||
|
2023
Q2 | $759K | Buy |
|
|||||
|
2023
Q1 | $669K | Buy |
|
|||||
|
2022
Q4 | $671K | Sell |
|
|||||
|
2022
Q3 | $2.98M | Sell |
|
|||||
|
2022
Q2 | $6.11M | Buy |
|
|||||
|
2022
Q1 | $7.02M | Buy |
|
|||||
|
2021
Q4 | $2.45M | Buy |
|
|||||
|
2021
Q3 | $1.91M | Buy |
|